Simplex Trading’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,198
| Closed | -$230K | – | 8436 |
|
|
2019
Q3 | $230K | Buy |
12,198
+7,889
| +183% | +$90.2K | ﹤0.01% | 3419 |
|
|
2019
Q2 | $50K | Sell |
4,309
-23,354
| -84% | -$283K | ﹤0.01% | 4871 |
|
|
2019
Q1 | $377K | Buy |
27,663
+27,203
| +5,914% | +$352K | ﹤0.01% | 2955 |
|
|
2018
Q4 | $4K | Sell |
460
-7,949
| -95% | -$102K | ﹤0.01% | 6374 |
|
|
2018
Q3 | $140K | Sell |
8,409
-4,205
| -33% | -$76K | ﹤0.01% | 4065 |
|
|
2018
Q2 | $199K | Buy |
+12,614
| New | +$192K | ﹤0.01% | 3499 |
|
|
2018
Q1 | – | Sell |
-8,126
| Closed | -$118K | – | 7302 |
|
|
2017
Q4 | $93K | Buy |
8,126
+3,465
| +74% | +$38.7K | ﹤0.01% | 1864 |
|
|
2017
Q3 | $57K | Sell |
4,661
-25,708
| -85% | -$268K | ﹤0.01% | 2194 |
|
|
2017
Q2 | $347K | Buy |
30,369
+29,103
| +2,299% | +$538K | 0.02% | 858 |
|
|
2017
Q1 | $26K | Buy |
1,266
+1,237
| +4,266% | +$27.4K | ﹤0.01% | 3008 |
|
|
2016
Q4 | $0 | Buy |
+29
| New | +$754 | ﹤0.01% | 6893 |
|
|
2016
Q3 | – | Sell |
-296
| Closed | -$9.01K | – | 6823 |
|
|
2016
Q2 | $7K | Sell |
296
-13,268
| -98% | -$359K | ﹤0.01% | 3990 |
|
|
2016
Q1 | $332K | Buy |
13,564
+10,404
| +329% | +$241K | 0.03% | 607 |
|
|
2015
Q4 | $104K | Sell |
3,160
-20,186
| -86% | -$683K | 0.01% | 1330 |
|
|
2015
Q3 | $764K | Buy |
23,346
+21,268
| +1,023% | +$904K | 0.06% | 309 |
|
|
2015
Q2 | $110K | Buy |
+2,078
| New | +$75.6K | 0.01% | 1156 |
|
Simplex Trading's ALDR Position: Q4 2019 in Review
Simplex Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,198 shares — an estimated $230K sold.
Simplex Trading first reported a position in ALDR in Q2 2015 and held it in 16 quarters. The position peaked at $764K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Simplex Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Simplex Trading sold 12,198 Alder Biopharmaceuticals shares in Q4 2019, an estimated $230K.
- Simplex Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 16 quarters.
- Simplex Trading's Alder Biopharmaceuticals position peaked at $764K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.